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1. Introduction 
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrotic vasculopathy 
and excessive organ fibrosis. Endothelial and vascular damage are main leading disability in 
SSc. The goal of treatment lies in the prevention of excessive fibrosis affecting major organs 
such as lung, esophagus or skin, and in minimizing microvascular injury to lessen the 
deterioration in quality of life. Raynaud’s phenomenon is the clue of early diagnosis that 
present vascular damage developing in the preclinical stage of SSc in 80-90% of patients. 
Nailfold capillaroscopy (NFC) is a easily accessible diagnostic tool in secondary Raynaud’s 
phenomenon. Examination of the nailfold capillaries can reveal the nature and extent of 
microvascular pathology in patients with SSc. Several prominent nailfold capillary changes, 
for example, megacapillary, capillary hemorrhage, loss in capillary distribution, is 
distinctively apparent in SSc. 
 The main cytokines that induce fibrosis from fibroblasts and endothelial cells are 
transforming growth factor-┚ (TGF-┚), interleukin-1 (IL-1), endothelin-1 (ET-1), tumor 
necrosis factor-┙ (TNF-┙). Especially, ET-1 was reported to play an important role in 
vasoconstriction, stimulation of fibroblasts growth incurring serious complications of SSc, 
such as, pulmonary fibrosis or pulmonary hypertension. These aberrant biochemical 
processes may involve systemic microcirculation and, thus, cause diffuse vascular 
abnormalities. 
2. Optimal NFC parameter in SSc 
Nailfold capillary is represent microcirculation (Figure 1). NFC is a well-established imaging 
technique widely used for diagnostic purposes in rheumatology as well as in other diseases, to 
assess features of microcirculation in vivo. Nailfold videocapillaroscopy enables the study of 
several aspects of capillary vessels, including morphology, distribution, density and blood 
flow. For Significant correlation between the results of NFC and microvascular injury and lung 
involvement was reported. Therefore, severity of the disease or response to the treatment 
could be estimated. Recently, researches on new factors in NFC, that would enable earlier 
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detection of change in clinical conditions and microvascular injury with computer-based 
digitalied analysis, are underway. Despite these advantages, there is some debate regarding 
the optimal parameter in assessing microvascular injury reflecting clinical status. 
 
Fingernail
Cuticle
Nail fold
capillary
 
Fig. 1. Scheme of nailfold capillary 
2.1 Study design 
We carried out this study to define the value of optimal NFC parameter in patients 
diagnosed as SSc, by investigating correlation between clinical manifestations and plasma 
ET-1 which are known to reflect disease activity. 
2.1.1 Patients and investigations of clinical manifestations 
Sixty patients were randomly selected from those fulfilling American College of 
Rheumatology criteria for SSc and whom visited outpatient clinic. 30 healthy controls were 
chosen from adults with no known medical history, and 23 disease controls were chosen 
from the patients with connective tissue disorders other than SSc. The disease control group 
consisted of 14 systemic lupus erythematosus (SLE), 4 primary Sjogren’s syndrome (pSS), 2 
dermatomyositis (DM), 2 mixed connective tissue disease (MCTD) and 1 rheumatoid 
arthritis (RA) patient. 
All patients and controls underwent NFC and blood sampling. After removing plasma from 
blood, the sample was stored at -70˚C freezer (ULT-1386-5D-40) in order to measure ET-1. 
Evaluation of patient group’s clinical manifestations was done with following exams; 
manometry and gastrofiberscopy to discover gastric involvement, pulmonary function test 
(PFT) and chest HRCT to discover pulmonary fibrosis, echocardiography to discover 
pulmonary hypertension, urinalysis and kidney sonography to discover renal involvement. 
Symptomatically, the presence of arthralgia, arthritis and digital ulceration was 
investigated. Assessment of skin sclerosis was done by an experienced rheumatologist, 
converting the severity into score using Modified Rodnan Score (MRS) (range : 0-51). 
Antinuclear antibody (ANA), Anti scl-70 antibody, Anti centromere antibody, extracellular 
nuclear antigen (ENA) was measured by immunoblot method. 
2.1.2 Nailfold capillaroscopy 
Patients were kept inside the procedure room for a minimum of 15 minutes before the 
nailfold analysis can be performed, to adapt to the room temperature of 20–25 ℃. Each 
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subject seated with dorsum of hand facing upwards, and with halogen lightings 
illuminating upon the nails coated with immersion oil, under nailfold microscopy. The NFC 
examination was performed by an experienced examiner without the patient’s clinical 
information and nailfolds of second, third and fourth digits of both hands were observed 
with light microscope (Olympus SZ-PT, Japan) under 100 times and 400 times magnification 
(Figure 2). All microphotographs were transmitted to computer by digital camera (Polaroid, 
USA) and after saving the images, enhancement was done by color filtering using Adobe 
Photoshop® ver. 7.0 for analysis. Quantitative analysis was done by counting total number 
of capillaries and number of capillaries with deletion, which were observed within 3mm 
width of the central part of digits. The results were recorded in average value of 6 digits. 
Also, an experienced rheumatologist measured the apical limb width and capillary width of 
3 capillary rings located at the center, where resolution is the finest, directly from computer 
screen, from all 6 digits (Figure 3). Previous reports have suggested that activity of SSc is in 
strong correlation with capillary width and apical limb width, but not capillary length. 
Therefore, we presumed that measuring capillary dimension at fixed capillary length 
(25um) could be a new parameter. We defined capillary dimension as the sum of pixel 
numbers of the area set by measuring capillary boundary at capillary length of 25 um. (1cm 
on x 400) Adobe Photoshop® ver. 7.0 was used in this process (Figure 4). 
 
 
Fig. 2. Nailfold capillaroscopy is a safe and noninvasive tool that possible to detect the 
progression of the morphological changes. 
(1)
(2)
 
Fig. 3. Scheme of capillary loop measurements (× 400). (1) Apical limb width, (2) Capillary 
width. 
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25μm
 
Fig. 4. The method of calculating “the sum of pixel number” with Adobe Photoshop® 
version 7.0 as reflect of capillary dimension: A perpendicular length of 25um tangent to 
internal limit of a capillary loop transverse segment defined the transverse segment area. 
2.1.3 Measurement of plasma endothelin-1 and Statistical analysis 
Plasma concentration of ET-1 was measured with ELISA (enzyme-linked immunosorbent 
assay) method. 500 uL of plasma ET-1 in EDTA tube was evenly mixed with 750ul of 
extraction solvent (acetone : 1N HCl :Water (40 : 1 : 5)) and then microcentrifuged. The 
supernant was dried down for 7 hours using speedVac concentrator and ET-1 ELISA kit 
(R&D, Minneapolis, MN, USA) was used for measurement. The results were interpreted 
using a microplate reader set to 450 nm as reference wavelength. The results were expressed 
in median values and inter-quartile range. SPSS ver. 17.0 program for Windows (SPSS, 
Chicago, IL) was used for statistical analysis. Mann-Whitney test was used for the 
comparison of NFC parameters and continual variables of ET-1, and Chi-square test and 
Fisher’s exact test was used for the comparison of clinical manifestations, between the SSc 
patient group and the control groups. Spearman’s correlation coefficient was used to 
express the relationship between MRS, measurement parameters of NFC, and plasma levels 
of ET-1 in SSc. All results were interpreted to be statistically significant when p value < 0.05. 
2.1.4 Results 
There were 30 people of diffuse type of systemic sclerosis (dSSc), and 30 people of limited 
type (lSSc). The mean age of 60 patients is 47 years old (12 - 66 years); 52 people are women 
(84%), the mean prevalence period is 4 years (0.1-18 years), which is similar in the sexual 
ratio and the age compared to the control groups. 57 people (95%) of SSc have Raynaud 
phenomena and it was more frequent than the disease control group. Raynaud phenomenon 
period is 12 months (1-120 months), statistically longer than the disease control group, 
which is 6 months (3-24months). Among the clinical manifestations, dysfunction due to 
gastrointestinal sclerosis, pulmonary fibrosis, arthralgia, arthritis, and digital ulcer were 
significantly frequent in SSc (Table 1). The difference in clinical patterns due to the subtypes 
of SSc was significantly elevated in the outbreak frequency of MRS high scores, 
gastrointestinal dysfunction, pulmonary fibrosis, and digital ulcer in the dSSc than the lSSc. 
On the contrary, there was no difference in Raynaud phenomenon, pulmonary 
hypertension, renal diseases, arthralgia, and arthritis. Statistically, autoantibody such as 
ANA, anti scl-70 antibody, ENA showed more positive incidence in the dSSc (Table 2). 
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Healthy Controls Disease control* SSc 
(N =30) (%) (N =23) (%) (dSSc=30, lSSc=30) (%) 
Female sex , n (%) 30 (100) 23 (100) 52 (83.87) 
Age, yrs, median (IQR) 30 (24-53) 41 (18-57) 47 (12-66) 
Disease duration, yrs, median 
(IQR) 
 5 (0.5-10) 4 (0.1-18) 
Raynaud’s phenomenon 0 (0) 10 (43.48) 57 (95.0) 
Duration of Raunaud’s ph, 
months, median (IQR) 
 6 (3-24) 12 (1-120) 
GI manifestation 0 (0) 0 (0) 29 (48.33) # 
Pulmonary fibrosis 0 (0) 2 (8.70) 33 (55.0) # 
Pulmonary Hypertension 0 (0) 2 (8.70) 3 (5.0) 
Renal disease 0 (0) 1 (4.35) 3 (5.0) 
Arthralgia 0 (0) 11 (47.83) 45 (75.0) # 
Arthritis 0 (0) 2 (8.70) 14 (23.33) # 
Digital ulceration 0 (0) 5 (21.74) 27 (45.0) # 
Table 1. Clinical characteristics of control and patients with SSc. 
 Diffuse type of 
SSc 
Limited type of 
SSc 
 
p- value 
(N =30) (%) (N=30) (%) 
Clinical    
Raynaud’s phenomenon 28 (93.33) 29 (96.67) NS 
Modified Rodnan score, IQR 10.5 (4-33) 4 (2-18) p<0.05* 
GI manifestation 19 (63.33) 10 (33.33) p<0.05* 
Pulmonary fibrosis 19 (63.33) 14 (46.67) p<0.05* 
Pulmonary Hypertension 1 (3.33) 2 (6.67) NS 
Renal disease 1 (3.33) 2 (6.67) NS 
Arthralgia 23 (76.67) 22 (73.33) NS 
Arthritis 7 (23.33) 7 (23.33) NS 
Digital ulceration 17 (56.67) 10 (33.33) p<0.05* 
Serological positivity    
 ANA (>1:160) 30 (100) 24 (80.0) p<0.05* 
Anti scl-70 Ab 18 (60.0) 12 (40.0) p<0.05* 
Anticentromere Ab 3 (10.0) 4 (13.33) NS 
 ENA 15 (50.0) 6 (20.0) p<0.05* 
Table 2. Clinical and serological finding according to type of SSc 
2.1.5 Results of NFC parameter 
In healthy control, nailfold capillary looks like comb-like patten with minor disorganization 
and tortousity (Figure 5). Not like uniformly ordered capillary shape in the healthy control 
group, there was statistical significance in the smaller number of capillaries within 3mm, 
increased deletion numbers, apical limb with, capillary width, capillary hemorrhage and 
dimension of capillary loop in SSc patient group. 
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(A) (B)
(C) (D)
 
Fig. 5. The example of NFC finding (x400): (A)(B) In healthy control, the field of observation 
is rather uniform as comb-like appearance. (C)(D) Minimal change of capillary dilatation 
and increased tortousity are also seen even in healthy control. 
The nailfold capillaroscopic pattern of early SSc is characterized by the massive dilatation 
and presence of giant capillaries (homogeneous and symmetrical capillary enlargement over 
10 times compared with normal pattern) and microhemorrages (Figure 6-A,B) (early to 
active pattern). At the late phase of SSc progresses into fibrosis, the capillaroscopic pattern 
most likely reflects the effects of capillary destruction, loss of capillaries, and avascular areas 
are observed along with ramifications and bushy capillaries (Figure 6-C,D) (late pattern). 
 
(A) (B)
(C) (D)
 
Fig. 6. The example of NFC finding (x400): (A)(B) In early to active phase of SSc, typically 
many giant capillary and microhemorrage is noted. (C)(D) At the late phase, ramified 
capillaries and avascular areas are observed along with bushy capillaries. 
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Above all, the capillary dimension presented as the sum of pixel numbers per 25 um 
capillary length was 1097, which showed the biggest difference; 516 from the healthy control 
group, 561 from disease control group (p <0.001) (Table3-1). Median and range of plasma 
ET-1 of the SSc patient group, normal control group and disease control group are on Table 
3-1. The SSc patient group and disease control group had higher plasma ET-1 level than 
normal control group. 
 
 Healthy Controls Disease control SSc 
(N =30) (N =23) (N =30) 
NFC feature, median 
(IQR) 
   
No. of loop (in 3mm) 21.8 (16-28) 20 (13.5-25) 11.8 (1-19.5)* 
Deletion No. of loop 0.5 (0-2) 1 (0.5-5.5) 3 (0-13)* 
Apical width (um) 9.2 (6.7-13.3) 9.5 (6.7-11.8) 14.23 (7.9-30)* 
Capillary width (um) 19.6 (12.5-26.7) 25 (15-49.7) 37.5 (15-100.9)* 
Capillary dimension# 515.9 (357-566) 561.0(420-920) 1096.7(312.6-2134)* 
Endothelin-1(pg/ml), 
median (IQR) 
1.7 (0.5-2.5) 2.1 (1.2-4.1)#a 2.4 (0.9-6.3)#b 
#Capillary dimension is presented by the sum of pixel number 
IQR: Inter-quartile range, median(range: minimum-maximum)  
* : p <0.05 is significant value 
#a : p <0.05 between disease control and heatrhy control group 
#b : p <0.05 between SSc and heatrhy control group 
Table 3-1. Nailfold capillary microscopic feature and plasma endothelin-1 level 
Other than that the capillary dimension of the dSSc was significantly wider than that of the 
lSSc, there was no difference between the two subtypes. There was no difference in the 
levels of plasma ET-1 among the subtypes of SSc patient group (Table 3-2). 
 
 dSSc lSSc  
p- value (N =30) (N =30) 
NFC feature, median (IQR)    
No. of loop (in 3mm) 10.1 (3-30) 13.5(3.5-23) NS 
Deletion No. of loop 3 (0.5-13) 3 (0-8) NS 
Apical width (um) 14.75(7.5-35) 12.75(8-30) NS 
Capillary width (um) 40.25(8-100.75) 35.13(21.68-88.35) NS 
Capillary dimension# 1312.7(313-2097) 965.1(527-2156) p<0.05* 
Endothelin-1 (pg/ml), median (IQR) 2.63(0.86-4.54) 2.21(1.09-6.31) NS 
Table 3-2. Nailfold capillary microscopic feature and plasma endothelin-1 between diffuse 
and limited type in patients with Systemic sclerosis. 
The NFC parameters did not differ in the presence of pulmonary fibrosis, renal diseases, 
arthralgia and arthritis in SSc. However, the number of capillaries in 3mm and capillary 
deletion had statistically significant smaller in gastrointestinal dysfunction and pulmonary 
hypertension. When there is a digital ulcer, all parameters of NFC showed significant 
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disparity, especially in number of capillary deletions (p <0.01) and capillary dimension (p 
<0.001) (Table 4). 
Comparison of plasma ET-1 of SSc patient group divided according to clinical characteristics 
showed notably high in the group with digital ulcer and pulmonary hypertension (p < 0.01, 
p < 0.05) (Table 4). It should be noted that plasma ET-1 is statistically proportional to MRS. 
Moreover, there was a statistic correlation between the level of plasma ET-1 and the 
capillary dimension in NFC (Table 5). 
 
 Clinical manifestation 
G-I 
Pul. 
fibrosis
Pul. HTN
Renal 
dis. 
Arthralgia Arthritis 
Digital 
ulcer 
NFC feature        
No. of loop  
(in 3mm) 
p <0.01* NS p <0.01* NS NS NS p <0.05* 
Deletion No. of loop p <0.05* NS p <0.01* NS NS NS p <0.01* 
Apical width NS NS NS NS NS NS p <0.05* 
Capillary width  NS NS NS NS NS NS p <0.01* 
Capillary 
dimension# 
NS NS NS NS NS NS p <0.001* 
Endothelin-1 NS NS p <0.05* NS NS NS p <0.01* 
#Capillary dimension is presented by the sum of pixel number 
G-I:abnormal finding in manometry including of GERD (gastro-esophageal reflux disease) 
Pul. fibrosis: Pulmonary fibrosis 
Pul. HTN: Pulmonary Hypertension  
Renal dis.: Renal disease 
NS: not significant 
p <0.05* is significant value 
Table 4. Correlation of clinical manifestations with NFC parameters and cytokines in 
patients with SSc. 
 
 Endothelin-1 
Skin hardness (MRS) p <0.05* 
NFC feature  
No. of loop  NS 
Deletion No. of loop NS 
Apical width  NS 
Capillary width  NS 
Capillary dimension# p <0.05* 
MRS: modified rodnan score 
SSc: Systemic sclerosis 
#Capillary dimension is presented by the sum of pixel number 
NS: not significant 
p <0.05* is significant value by Spearmam’s correlation. 
Table 5. Correlation of plasma endothelin-1 with skin hardness and NFC parameters in 
patients with SSc 
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The level of plasma ET-1 and the capillary dimension were notably correlated in all of 
healthy, disease control group and SSc patient group (Rs = 0.82 / p<0.001, Rs = 0.83 / 
p<0.001, Rs = 0.31 / p<0.05) (Figure 7). The results suggest that computer-based microscopic 
analysis of NFC is a useful method that potentially provides information on organ 
involvement and plasma ET-1. 
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Fig. 7. Relationship between plasma Endothelin-1 and capillary dimension; Capillary 
dimension showed strong correlation with the level of endothelin-1 in (A) healthy control, 
(B) disease control, (C) SSc (p <0.05* is significant value by Spearmam’s correlation). 
3. Conclusion 
NFC is a non-invasive, relatively inexpensive modality in diagnosing secondary Raynaud’s 
phenomenon and it detects characteristic changes of SSc. NFC is able to indirectly evaluate 
vascular function of the connective tissue disorder. Recent researches reported the 
correlation between the NFC change and the occurrence of gastrointestinal invasion, 
pulmonary fibrosis, portal hypertension; thereby there is increasing the possibilities of the 
early detection of internal organ invasion or the marker for the follow-up after treatment 
based with digitalized computer-based analysis. Many clinical findings and plasma 
cytokines was compared with traditionally used NFC parameter, which to observe the 
number of capillaries and deletions in 3mm, apical limb width and the capillary width itself; 
however, we suggest that a computer can generate a more powerful relation which predicts 
the capillary dimension presented as the sum of pixel number in 25um of length. 
Previously anderson et al. asserted that capillary dimension could be a new parameter for 
Raynaud phenomenon; there were differences in capillary dimension according with 
diabetic’s vasospastic symptoms. Also in our study, the capillary dimension positively 
correlates with the apical limb width and capillary width in healthy control group. In 
disease control and SSc group, the capillary dimension negatively correlates with the 
number of capillary and showed positive correlations to the rest parameters, which 
advocates as a new optimal parameter. The capillary dimension also is illustrated statistic 
correlation to MRS which is the distinctive symptom in SSc. Additionally, the capillary 
dimension increases the most with the incidence of digital ulcer, which best reflects the 
activity of the disease in general. Not only in SSc, capillary dimension represented an 
authentic correlation to plasma ET-1 level in both the healthy control and the disease control 
group. For those reasons, the capillary dimension can be a factor that speaks for plasma ET-
1, regardless of the disease types. 
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The endothelial cell or the smooth muscle cell secretes ET-1, which is a strong 
vasoconstrictor related to the onset of numerous diseases. ET-1 is known to the main 
cytokine which causes capillary deletion and directly to the development of fatal diseases 
such as pulmonary fibrosis and portal hypertension in SSc. As like in other studies, in SSc, 
plasma ET-1 level was increased than the healthy control group, but there was no statistic 
difference with the disease control group. The reason is that ET-1 is also increased in other 
connective tissue disorders that involve microvessel disruption due to vasoconstriction. 
Scala et al. emphasized the research and control of essential cytokines that overproduces or 
causes unbalance in extracellular materials in connective tissue cells, among many causes of 
fibrosis, is adequate for pathophysiologic approach to the disease and to prevent the 
progress of the disease. On the other hand, it is troublesome to measure the changes of 
cytokines all the time and the relationship to internal organ invasion is uncertain. 
From this study, plasma ET-1 is elevated in SSc than the healthy control group 
proportionately to MRS, and meaningfully high in digital ulcer and pulmonary 
hypertension. For that reason, ET-1 could be considered to be closely related to the disease 
progression and severity of SSc. In our study, the capillary dimension is the best reflects of 
plasma ET-1 in the NFC parameters. Consequently, capillary dimension using computer 
pixel number is able to assume according to increasing in the plasma ET-1 and disease 
activity. Capillary dimension maybe a powerful parameter, could be advantageous for early 
diagnosis of complications as a result of organ involvement, and for the regular follow-ups 
to assessments of the treatment in the patients with SSc. 
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